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Plasmin Plays a Role in the In Vitro Generation of the
Linear IgA Dermatosis Antigen LADB97
Silke C. Hofmann1, Ursula Voith1, Verena Scho¨nau1, Lydia Sorokin2, Leena Bruckner-Tuderman1 and
Claus-Werner Franzke1,3
Collagen XVII (BP180) and its shed ectodomain represent major autoantigens in dermatoses of the pemphigoid
group. The 120 kDa ectodomain is constitutively shed from the cell surface by disintegrin-metalloproteinases
(ADAMs). Part of it is further processed to a 97 kDa fragment (LABD97), an autoantigen in linear IgA dermatosis
(LAD), but the responsible proteinases remain elusive. In this study, we identified the 120 and the 97 kDa
ectodomain in blister fluids of bullous pemphigoid patients using new mAbs. As blister fluids contain
significant plasmin-like serine protease activity, HaCaT keratinocytes or purified 120 kDa ectodomain were
incubated with several human serine proteases. In vitro, only plasmin generated a stable 97 kDa fragment that
was also targeted by LAD sera. Characterization of the plasmin-derived 97 kDa fragment with domain-specific
collagen XVII antibodies, heparin binding and N-glycosylation studies indicates that the N-terminus is located
approximately at AA 515 and the C-terminus N-terminally from AA 1,421. Interestingly, plasmin-derived LABD97
was also generated in the presence of ADAM inhibitors and remained stable over more than 12 hours
incubation at 37 1C, indicating that this disease relevant collagen XVII fragment can also arise in an ADAM-
independent manner through direct action by plasmin.
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INTRODUCTION
Collagen XVII (BP180) is a hemidesmosomal type II
transmembrane protein that promotes adhesion of basal
keratinocytes to the underlying basement membrane (Borra-
dori and Sonnenberg, 1996), as demonstrated by its involve-
ment in human pathology. Mutations in the collagen XVII
gene, COL17A1, cause junctional epidermolysis bullosa
(Pulkkinen and Uitto, 1998). In bullous pemphigoid (BP),
autoantibodies target immunodominant epitopes mainly
located within the juxtamembranous NC16a domain of
collagen XVII (Powell et al., 2005). As shown by passive
transfer mouse models and in vitromodels, antibodies against
collagen XVII are pathogenetically relevant as their binding to
the antigen induces complement activation leading to
neutrophil infiltration, secretion of proteases and epidermal-
dermal separation (Sitaru et al., 2002; Liu, 2004).
In linear IgA dermatosis (LAD), a rare subepidermal
bullous autoimmune dermatosis with clinical and immuno-
pathological features overlapping with BP, the ectodomain of
collagen XVII is specifically targeted by IgA-autoantibodies
(Schumann et al., 2000). LAD is characterized by pruritic
tense blisters often occurring in a ‘‘cluster of jewels’’
arrangement and by tissue-bound and circulating IgA-
autoantibodies against the basement membrane zone (Egan
and Zone, 1999). In addition to the shed 120 kDa ectodomain
of collagen XVII, initially coined LAD-1, the IgA-autoanti-
bodies also recognize a 97 kDa antigen, designated LABD97,
that represents a truncated form of the collagen XVII
ectodomain (Marinkovich et al., 1996; Zone et al., 1998;
Egan et al., 2001).
It has been shown that the autoantigens LABD97 and LAD-1
have different N-termini (Hirako et al., 2003), most probably
due to the involvement of different proteinases. Within the
NC16a domain, which spans amino acid (AA) residues
490–567 of collagen XVII, the N-terminus of LABD97 was
located to Ala531 (Zone et al., 1998) and that of LAD-1 to
Leu524 (Hirako et al., 2003).
We have shown that the 120 kDa ectodomain of collagen
XVII is constitutively shed from the cell surface under
physiological conditions by metalloproteinases of the
ADAMs family, an acronym for a disintegrin and metallo-
proteinase. Shedding is regulated by the plasma membrane
microenvironment and ectophosphorylation (Franzke et al.,
2002; Zimina et al., 2007). To date, the proteases responsible
for processing of the ectodomain to LABD97 have remained
unknown.
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Serine proteases and metalloproteinases, such as neutro-
phil elastase, plasmin, plasminogen activators, MMP-2 and
MMP-9, have been detected in BP blister fluids and in
perilesional skin (Oikarinen et al., 1983; Grando et al., 1989;
Stahle-Backdahl et al., 1994). In addition, elevated levels of
plasmin or tissue-type plasminogen activator (tPA) in BP
blister fluids and skin lesions suggest a function for the
plasminogen/plasmin system in the pathogenesis of BP and/or
in the regeneration of lesional tissue (Baird et al., 1990;
Gissler et al., 1992; Kramer and Reinartz, 1993; Venning
et al., 1993). Plasminogen is mainly produced in the liver.
After wounding or blistering of the skin, plasminogen will
diffuse from the blood stream to the skin and will be activated
by plasminogen activators or other serine proteases (Lund
et al., 2006). The activators, tPA and urokinase-type
plasminogen activator (uPA), are expressed in keratinocytes,
thus providing a mechanism for the generation of active
plasmin in the skin (Jensen et al., 1988; Schmidt et al., 2004).
The function of the plasminogen/plasmin system in the
pathogenesis of BP has also been suggested by the finding
that plasminogen- and tPA-deficient mice and wild-type mice
treated with plasmin inhibitors are resistant to experimental
BP (Liu et al., 2005). Furthermore, in vitro treatment of
normal human keratinocytes with BP antibodies leads to
release of tPA into the culture supernatant (Schmidt et al.,
2004).
In this study, we generated highly reactive mAbs to
collagen XVII and used them to characterize the plasmin-
generated stable 97 kDa fragment of the collagen XVII
ectodomain that represents an autoantigen in LAD.
RESULTS
Epitope mapping of monoclonal antibodies NC16a-1 and
NC16a-3
To generate high quality tools to characterize collagen XVII
and its fragments, mAbs were raised against the NC16a
domain. For epitope mapping of hybridomas with binding to
the blister roof of sodium chloride-split human skin by
indirect immunofluorescence, three different GST-NC16a-
fusion proteins were used (Figure 1a): FL-NC16a representing
the entire NC16a domain, N-NC16a representing the
N-terminal part of the NC16a domain (AA 490–523) and
C-NC16a encompassing the C-terminal part of the NC16a
domain (AA 525–567). Immunoblotting of these recombinant
NC16a fragments with the hybridomas revealed two particu-
larly interesting clones, termed NC16a-1 and NC16a-3.
Although NC16a-1 recognized the N-terminal NC16a frag-
ment, NC16a-3 bound specifically to C-NC16a (Figure 1b).
Both mAbs were of the IgG1 isotype and reactive with
180 kDa full-length collagen XVII in keratinocyte extracts and
with the 120 kDa shed ectodomain in conditioned medium.
However, mAb NC16a-3 reacted significantly stronger with
the shed 120 kDa ectodomain than with full-length collagen
XVII.
For more precise epitope mapping, a pepspot assay with
35 overlapping 13-meric synthetic peptides, covering the
entire NC16a domain, was used. NC16a-1 specifically bound
to pepspots 12–14, with the most intense staining at spot 13
(AA 513–525 of collagen XVII). The epitope of mAb NC16a-1
can therefore be narrowed down to AA 515–523. Subse-
quently, after pH shift stripping, the assay was reprobed with
NC16a-3, which reacted specifically with pepspot 29
(corresponding to AA 545–557) (Figure 1c and d).
A 97 kDa fragment of the collagen XVII ectodomain in blister
fluids
In a previous study, we used mAb NC16a-1 to immunopre-
cipitate the 120 kDa ectodomain from blister fluids in BP and
suction blisters induced on normal skin (Zimina et al., 2008).
The precipitated ectodomain was visualized by immuno-
blotting with a polyclonal rabbit anti-NC16a antibody
(Schumann et al., 2000). Interestingly, in about 60% of the
BP blister fluids, but only in 25% of the suction blister fluids,
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Figure 1. Epitope mapping of the mAbs NC16a-1 and NC16a-3. (a) Scheme
of full-length collagen XVII and the recombinant GST-fusion proteins used for
antibody production and epitope mapping. Top: Collagen XVII consists of an
intracellular domain (ICD), the NC16a domain adjacent to the
transmembrane domain, and an extracellular domain (ECD) with 15
interrupted collagenous subdomains (black rectangles). Bottom: Three NC16a
recombinants FL-NC16a, N-NC16a, and C-NC16a. (b) The mAb NC16a-1
specifically binds to the N-terminal part of the NC16a domain (AA 490–523),
whereas NC16a-3 recognizes a more C-terminal region (AA 525–567). Serum
of the mouse immunized with FL-NC16a (pNC16a) showed reactivity to the
entire NC16a domain. Molecular weight marker is shown on the right. (c)
Using a pepspot assay NC16a-1 reacted with spots 12–14, which localizes the
epitope to AA 515–523 (upper panel). Subsequently, after stripping, the assay
was reprobed with NC16a-3 (lower panel) which reacted specifically with
spot 29, revealing AA 545–557 of collagen XVII as epitope of NC16a-3. (d)
Localization of the epitopes (underlined) within the NC16a sequence.
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an additional 97 kDa protein was precipitated in large
quantities by mAb NC16a-1 (Figure 2a). To understand the
mechanism of collagen XVII shedding in blister fluids, we
performed time-chase experiments on suction blisters on
normal skin. Four suction blisters were induced on the
forearm of an individual and punctured after 0, 6, 10, and
20 hours. Immunoprecipitation with mAb NC16a-1 yielded
increasing amounts of the 97 kDa fragment with time (Figure
2b). We predicted that this fragment corresponds to the
C-terminally truncated form of the collagen XVII ectodomain,
which was initially designated LABD97.
Active plasmin is present in blister fluids
To identify the protease responsible for cleavage of the
collagen XVII ectodomain to LABD97, we first proceeded
to analyze the proteolytic activity in the blister fluids
using chromogenic substrates. Although the usage of elastase
substrate N-succinyl-L-alanyl-L-alanyl-L-alanine 4-nitroanilide
showed no differences in activities between BP blisters and
control blisters (data not shown), the usage of plasmin
substrate N-(p-Tosyl)-Gly-Pro-Lys 4-nitroanilide (Lottenberg
et al., 1981) revealed significantly higher activity in BP
blister fluids than in fresh suction blisters (Figure 3a). The
presence of plasmin in BP blister fluids and sera is
demonstrated by SDS–PAGE under nonreducing conditions
and immunoblotting with a mAb to human plasminogen/
plasmin (Figure 3b).
Plasmin produces a stable 97 kDa fragment of collagen XVII
ectodomain
The next question was whether plasmin cleaves collagen
XVII. This was tested by incubating the purified ectodomain
of collagen XVII with different human serine proteases,
including plasmin, neutrophil elastase, trypsin, and chymo-
trypsin. Of these, only plasmin produced a 97 kDa fragment
(Figure 4a, left panel). Incubation of HaCaT keratinocytes
with human plasmin and trypsin for 2 hours resulted in the
production of a 97 kDa fragment, although trypsin generated
additional smaller fragments (Figure 4a, right panel). Further
comparison of plasmin and trypsin treatments of HaCaT cells
for over 12 hours revealed that only plasmin generated a
stable 97 kDa collagen XVII fragment (Figure 4b).
Generation of the 97 kDa fragment of collagen XVII ectodomain
is not ADAM dependent
To define whether plasmin cleavage of collagen XVII
depends on its physiological shedding from the cell surface
by ADAMs, HaCaT keratinocytes were preincubated with
50 mM of the hydroxamate metalloproteinase inhibitors
BB3103 (BB) or TAPI I (TA) for 5 hours, a procedure that
completely inhibits the ectodomain cleavage. This was
followed by addition of 0.5U of human plasmin to the
medium for 1 hour. Collagen XVII fragments in the super-
natant were visualized by immunoblotting with a polyclonal
rabbit-anti-NC16a antibody (Schumann et al., 2000). The
97 kDa fragment was also generated in the presence of
ADAM inhibitors, which indicates an ADAM-independent
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Figure 2. The collagen XVII ectodomain is detectable in blister fluids. (a) Blister fluids of 3 representative BP patients (BP1–BP3) and one representative
suction blister fluid (SB), and HaCaT medium (M) as a control were immunoprecipitated using the NC16a-1 mAb bound to protein A sepharose. Immuno-
precipitated proteins were immunoblotted and visualized with anti-NC16a antibody. The 120 kDa ectodomain of collagen XVII (black arrow) and a 97 kDa
fragment (grey arrow) was immunoprecipitated by NC16a-1 from the BP blisters. Most suction blisters punctured 4 hours after blister formation only contained
the 120 kDa ectodomain. (b) Immunoprecipitation of suction blisters punctured 0, 6, 10, or 20 hours after blistering, revealed that the 97 kDa collagen
XVII ectodomain (grey arrow) is present in suction blisters, if punctured more than 6 hours after blister existence. Molecular weight marker is shown on the right.
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Figure 3. Plasmin is present in blister fluids. (a) The plasmin-like serine
protease activity of nine BP blisters (BP) and seven directly punctured suction
blisters (SB) was measured by a chromogenic assay using N-(p-Tosyl)-Gly-
Pro-Lys 4-nitroanilide acetate as substrate. BP blisters contained significantly
higher levels of plasmin-like activity. (b) Immunoblot of BP blister fluids (1
and 2), BP serum (3) and control serum (4) with an antibody to human
plasminogen/plasmin showing a double band of the zymogen and the
activated enzyme at about 85 kDa in each sample. Molecular weight marker
is shown on the right.
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cleavage of collagen XVII within the NC16a domain
(Figure 4c).
Characterization of the 97 kDa collagen XVII fragment
The specificity of plasmin is not clearly understood, but it
cleaves C-terminal of arginine or lysine residues (Lottenberg
et al., 1981; Law et al., 1985). Therefore, the NC16a domain
contains 15 potential plasmin cleavage sites. N-terminal
sequencing of the purified 97 kDa fragment from plasmin-
incubated HaCaT keratinocytes did not result in a distinct
unique sequence, a fact that led us conclude that different
populations of N-termini were generated.
To further characterize the plasmin-cleaved 97 kDa
fragment, immunoblots were performed with two different
Con Pla Ela Try Chy Con Pla Ela Try Chy
kDa kDa
115
95
115
95
50 50
50
115
Con Try Pla Con Try Pla Con Try Pla
kDakDa
95
50
5 minutes 1 hours 12 hours
Con + +BB TA + kDa
200
115
95
Con + + +BB TA
SupernatantLysate
Figure 4. Plasmin digestion results in a stable 97 kDa collagen XVII ectodomain fragment. (a) Left panel: The purified 120 kDa collagen XVII ectodomain (black
arrow) was incubated without (Con) and with the human serine proteases plasmin (Pla), neutrophil elastase (Ela), trypsin (Try), and chymotrypsin (Chy) for
3 hours at 37 1C. Only plasmin produced a stable fragment at 97 kDa (grey arrow). (a) Right panel: HaCaT keratinocytes were incubated with no enzyme (Con),
plasmin (Pla), neutrophil elastase (Ela), trypsin (Try), and chymotrypsin (Chy) for 5 hours and the fragments in the supernatant were analyzed by immunoblotting
with rabbit-anti-NC16a antibody. Only the addition of plasmin and trypsin resulted in the production of a 97 kDa fragment. (b) Long-term digestions of HaCaT
cells with trypsin and 0.5U plasmin. Only the addition of plasmin to HaCaT cells resulted in the production of a stable 97 kDa fragment (grey arrow). This
fragment showed high stability over 5 hours and even 12 hours. (c) HaCaT keratinocytes were preincubated with 50 mM of the hydroxamate metalloproteinase
inhibitors BB3103 (BB) or TAPI I (TA) for 5 hours followed by addition of 0.5U human plasmin to the medium (þ ) and further 1 hour incubation. The fragments
in the lysates and supernatant were visualized by immunoblotting with rabbit-anti-NC16a antibody. The 97 kDa fragment was also generated in the presence of
ADAM inhibitors which point to an ADAM-independent cleavage of collagen XVII within the NC16a domain (white arrow, 180 kDa collagen XVII; black arrow,
120 kDa ectodomain; grey arrow, 97 kDa fragment).
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LAD sera (LAD 1 and 2). Both showed intense binding to the
97 kDa ectodomain indicating that the plasmin-cleaved
97 kDa fragment most likely corresponds to the autoantigen
LABD97 (Figure 5a). Using the polyclonal rabbit-anti-NC16a
antibody, we showed that the 97 kDa fragment from BP
blister fluid and plasmin-derived LABD97 from HaCaT
medium co-migrate (Figure 5a).
The molecular identity of the 97 kDa fragment was further
dissected using a panel of mono- and polyclonal antibodies
directed against the NC16a domain, the intracellular domain
(mAb V5–8) and the C-terminus of collagen XVII (Ecto-1) in
order to map the N- and C-termini of plasmin-derived
LABD97. The antibodies to the extreme N- and C termini of
collagen XVII, mAb V5–8 (Olaru et al., 2006) and Ecto-1
(Schacke et al., 1998), did not bind to LABD97, indicating
that the intracellular domain and the C-terminus of the
full-length collagen were not contained in this fragment.
In contrast, both mAbs NC16a-1 and NC16a-3 recognized
the fragment (Figure 5b and c), demonstrating that
the plasmin cleavage occurred N-terminally of the
previously published LABD97 terminus at AA531 (Zone
et al., 1998).
As collagen XVII has only one actively used N-glycosyla-
tion site at position 1,421 close to the distal C-terminus
(Schacke et al., 1998; Franzke et al., 2006), the sensitivity of
the 97 kDa fragment to peptide N-glycosidase F (PNGase F)
was tested. A mobility shift was seen when the 120 kDa
ectodomain was used as a substrate, but not with the 97 kDa
fragment (Figure 6a), further confirming that the C-terminus of
collagen XVII is not contained in LABD97. Taken together,
our immunomapping and digestion experiments place the
N-terminus of plasmin-derived LABD97 at approximately AA
515 and the C-terminus N-terminally of AA 1,421.
Plasmin-derived LABD97 has lower heparin binding capacity
than intact ectodomain
In addition, heparin binding of collagen XVII fragments
was investigated, because the released ectodomains of
transmembrane collagens type XIII, XXIII, and XXV are
known to have high affinity to heparin, which is mediated
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Figure 5. Immunomapping of the in vitro plasmin-cleaved 97 kDa collagen XVII ectodomain. (a) Extract of HaCaT keratinocytes (E), HaCaT medium in the
absence (M) or presence of plasmin (MP), and blister fluid of a BP patient (BF) were immunoblotted with rabbit-anti-NC16a-antibody (NC16a) or with serum of
two linear IgA dermatosis patients (LAD 1 and LAD 2). The LAD sera reacted weakly with the 120 kDa ectodomain (black arrow), but intensively with the
plasmin-cleaved 97 kDa fragment (grey arrow), which comigrated with the 97 kDa fragment present in BP blister fluids. (b) For epitope mapping of the plasmin-
cleaved 97 kDa fragment, immunoblots were reacted with mAbs NC16a-1 and NC16a-3 against the NC16a domain, mAb V5–8 against the intracellular domain
and polyclonal chicken Ecto-1 antibody against the C-terminus of collagen XVII. The 97 kDa fragment (grey arrow) was detected by the mono- and polyclonal
NC16a antibodies, but not by antibodies to the intracellular domain or the C-terminus of collagen XVII. (c) Schematic representation of the antibodies epitopes.
Full-length collagen XVII with the intracellular domain (ICD), NC16a domain, and extracellular domain (ECM) is depicted at the top, the collagen XVII
recognition sequences of the antibodies are shown at the bottom.
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by positively charged AA cluster regions (Tu et al., 2002;
Banyard et al., 2003). Heparin-affinity chromatography
revealed that the 120 kDa ectodomain eluted at 0.56M NaCl,
whereas plasmin-derived LABD97 eluted already at 0.39M
NaCl, indicating a lower heparin bonding capacity
(Figure 6b).
DISCUSSION
Collagen XVII is a major component of hemidesmosomes
and mediates a stable interaction of epidermal keratinocytes
with the extracellular basement membrane in tissue homeo-
stasis. When separation of basal keratinocytes from their
ligands in the basement membrane zone is required, for
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Figure 6. The 97 kDa collagen XVII fragment is unglycosylated and shows low heparin affinity. (a) Deglycosylation by PNGase F (PNG). The collagen XVII
ectodomain from untreated or plasmin-treated HaCaT medium was concentrated by salt precipitation and incubated with N-glycosidase F (PNG) before
immunoblot analysis. The 120 kDa collagen XVII ectodomain was sensitive to PNGase F digestion, as indicated by a motility shift of about 5 kDa, whereas the
plasmin-derived 97 kDa fragment yielded a single band after incubation with PNGase, indicating that C-terminally truncated collagen XVII was not glycosylated.
(b) The 120 kDa or plasmin-induced 97 kDa collagen XVII ectodomain from HaCaT medium was concentrated by salt precipitation and analyzed by HPLC with
a HiTrap Heparin HP column. The bound ectodomain was eluted with a gradient from 0 to 1M NaCl in 20mM Tris-HCl, pH 7.2 at a flow rate of 250 ml minute1.
All fractions were screened for collagen XVII immunoreactivity by immunoblotting with polyclonal rabbit-anti NC16a antibody and the density was determined.
The wild-type ectodomain eluted with 0.56 M NaCl, whereas the C-terminally truncated form eluted with 0.39M NaCl, indicating a lower heparin bonding
capacity.
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example during migration or differentiation, ADAMs shed the
120 kDa ectodomain of collagen XVII and release it into the
extracellular milieu (Franzke et al., 2002; Hirako et al.,
2003). Shedding analysis of deletion mutants revealed that
the stretch of AA 528–547 is important for constitutive
shedding of the 120 kDa ectodomain (Franzke et al., 2004).
Furthermore, an interaction model of ADAMs with collagen
XVII suggested a putative cleavage site between Gly539 and
Leu540 (Zimina et al., 2007). However, ADAMs do not
cleave site specific, which may lead to production of different
N-termini.
Here we show that after tissue injury, such as blister
formation, the collagen XVII ectodomain can also be cleaved
by plasmin to produce a stable 97 kDa fragment that is
recognized by LAD sera and, therefore, probably identical to
LABD97, an autoantigen in LAD. The molecular character-
istics of this fragment were delineated with protein biochem-
ical and immunochemical techniques. Repeated attempts
to identify the N-terminus of purified plasmin-derived
LABD97 by Edman degradation resulted in multiple over-
lapping sequences, indicating that more than one N-terminus
were present. It is very likely that several N-termini are
produced by plasmin cleavage, as the NC16a domain
contains 15 potential plasmin cleavage sites (6 Lys-X and 9
Arg-X peptide bonds) that are preferentially clustered in four
distinct regions. In addition, concomitant ADAM cleavage
may contribute to the diversity of generated N-termini.
Therefore, high-affinity mAbs, NC16a-1 and NC16a-3
with defined epitope regions were employed to determine the
N-terminus of plasmin-derived LABD97. Our immunoblot
analysis predicted the N-terminus at approximately AA 515,
and therefore clearly upstream of the previously described
N-terminus at Ala531, which does not represent a potential
plasmin cleavage site (Zone et al., 1998). This discrepancy
may be explained by the parallel production of different
N-termini by concomitant plasmin and ADAMs cleavage,
and by exopeptidase activity during the long and tedious
protein isolation protocol used. In this study, a highly
specific LABD97 mAb affinity column was used to purify
LABD97 from human epidermal extracts. As the precise
epitope of the mAb 97-1 is unknown, only one of the
different LABD97 species may have been selected (Zone
et al., 1998).
The C-terminus of plasmin-derived LABD97 is truncated
compared to the authentic shed ectodomain of collagen XVII.
This was demonstrated by the facts that LABD97 shows no
reactivity with the polyclonal Ecto-1 antibody directed
against unknown epitopes within the 205 most C-terminal
AAs of collagen XVII, has lower heparin binding capability,
and is not N-glycosylated. The loss of carbohydrate moieties
at the only glycosylation site of collagen XVII at position
1,421 (Schacke et al., 1998; Franzke et al., 2006) is likely to
influence the physicochemical abilities of the molecule, and
may lead to lower solubility or binding capacities (Chammas
et al., 1991). We have previously shown by protein–protein
interaction studies that the C-terminal region of collagen XVII
binds to laminin 332 (formerly laminin 5) (Tasanen et al.,
2004). Therefore, cleavage of collagen XVII by plasmin may
also be a mechanism to solubilize the ectodomain and to
alter cell adhesion.
The ectodomain of collagen XVII also binds heparin, a
property shared with transmembrane collagens type XIII,
XXIII, and XXV (Tu et al., 2002; Banyard et al., 2003; Osada
et al., 2005). In vitro heparin binding suggests putative
interactions with heparan sulfate proteoglycans, which are
important components of the basement membranes and
likely physiological ligands. Binding to heparin is mediated
through clusters of basic AAs, that is arginine, lysine and
histidine. In particular, clustered arginines seem to be
essential for heparin binding (Sasaki et al., 1999). Interest-
ingly, potential clusters are found within the NC16a domain,
but especially within the distal C-terminus in the Col-1
domain as a triple-helical cluster (Gly1468 to Lys1479) and
as a cluster of five arginines (Arg1487 to Arg1491). Both latter
stretches are abolished by plasmin cleavage; this may explain
the significantly lower heparin affinity of LABD97 compared
to the genuine ectodomain of collagen XVII.
Taken together, these results place the C-terminus of
plasmin-derived LABD97 at least N-terminally from AA
1,421. This finding is in line with the results of Zone et al.
(1998), who determined Arg1260, a potential plasmin
cleavage site, as possible C-terminus of LABD97 by
N-terminal sequencing of ArgC digestion derived fragments
of purified LABD97.
In the context of human skin blistering diseases, LABD97
has been known as a basement membrane autoantigen
for a long time (Zone et al., 1990; Ishiko et al., 1996), but in
spite of evidence that it corresponds to the extracellular
domain of collagen XVII (Zone et al., 1998), its molecular
characteristics have remained elusive. Using the high-affinity
mAbs NC16a-1 and -3 we detected the 97 kDa ectodomain
fragment in BP blisters and in suction blisters, if these were
older than 6 hours. Plasmin-like serine proteases and,
specifically, active plasmin were present in BP blisters, but
not in fresh suction blisters. These findings are in line with
other studies detecting high levels of plasmin and tPA in BP
blisters and aging suction blisters (Grando et al., 1989;
Schmidt et al., 2004). The detection of LABD97 in suction
blisters older than 6 hours suggests that the plasminogen/
plasmin system is involved in reparative processes such as
reepithelialization and wound healing (Toriseva and Kahari,
2008).
LAD sera seem to react preferentially with the 120 kDa
collagen XVII ectodomain and LABD97 (Egan et al., 1999;
Zillikens et al., 1999; Roh et al., 2000; Schumann et al.,
2000), whereas BP sera preferentially bind to the transmem-
brane form of collagen XVII. The lack of reactivity of LAD
sera with full-length collagen XVII suggests the generation of
neoepitopes by proteolytic cleavage. Given the high sensi-
tivity of direct and indirect immunofluorescence in the
diagnosis of LAD, these neoepitopes must be stably retained
within the skin basement membrane zone in vivo (Masunaga
et al., 1997).
The function of plasmin in cleaving transmembrane
molecules is of great pathophysiological interest. Here, we
demonstrate in vitro that plasmin has the capability to cleave
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collagen XVII directly to yield a 97 kDa fragment that is
recognized by LAD sera. Plasmin cleavage of collagen XVII
likely generates—potentially highly immunogenic—neoepi-
topes that may be involved in initiation of the autoimmune
dermatosis LAD. Increased cleavage may depend on a certain
genetic background with higher basal expression of plasmi-
nogen activators or on activation of plasminogen in the
context of repetitive cutaneous wounds (Toriseva and Kahari,
2008). Our in vitro experiments also demonstrated that
plasmin can shed collagen XVII in the absence of ADAM
activity. Similarly, shedding of the transmembranous heparan
sulphate proteoglycan syndecan-4 can be induced by
plasmin cleavage. Under physiological nonstimulated con-
ditions, the ectodomain of syndecan is shed constitutively by
metalloproteases (Park et al., 2000), but in a pathological
environment with strongly upregulated plasmin concentra-
tions, two new cleavage sites beside the physiological one,
were generated (Schmidt et al., 2005).
The plasmin-derived 97 kDa collagen XVII fragment
shares many characteristics with LABD97 isolated from
BP and suction blister fluids. Consequently, the plasmino-
gen/plasmin system is not only activated in experimental
BP by binding of collagen XVII antibodies (Schmidt et al.,
2004), but also by other, perhaps inflammatory, processes
during blister formation. Plasmin cleavage may lead to
disintegration of ligand interactions, which may be involved
in maintaining disease activity in LAD. Finally, the fact
that plasmin is involved in the pathogenesis of LAD, and
perhaps in other autoimmune blistering disorders, suggests
the usage of specific plasmin inhibitors as potential
therapeutics.
MATERIALS AND METHODS
Generation of monoclonal antibodies to the NC16a domain of
collagen XVII
For the production of bacterial GST fusion proteins as antigens, three
different cDNA fragments encoding the entire NC16a domain (AA
490–567, FL-NC16a), the N-terminal part (AA 490–523, N-NC16a)
or the C-terminal part (AA 525–567, C-NC16a) were amplified by
PCR using human collagen XVII cDNA as described previously
(Schumann et al., 2000) and cloned into the BamHI/EcoRI restriction
site of pGEX-6T-1 vector (Amersham Pharmacia Biotech, Piscat-
away, NJ). The constructs were verified by nucleotide sequencing,
expressed in Escherichia coli BL21 and the recombinant proteins
were purified using the GST-glutathione affinity system according to
the manufacturer’s instructions (Amersham Pharmacia Biotech) and
stored at 80 1C until use.
Balb/c mice were immunized three times with 30 mg of GST-FL-
NC16a fusion protein at weekly intervals. Mouse splenocytes were
fused with Sp2/0 myeloma cells as previously described (Sorokin
et al., 1992). Initial screening for antibody production was based on
indirect immunofluorescence using human skin; the specificity of the
antibodies was confirmed by immunoblotting with recombinant
GST-NC16a proteins and with keratinocyte extracts and medium.
Selected hybridomas were subcloned twice by limiting cell dilution
(Galfre and Milstein, 1981). For isotyping of the mAbs the Sigma
Immunotype mouse mAb isotyping kit (Sigma-Aldrich, St Louis, MO)
was used.
Epitope mapping of monoclonal antibodies
The precise epitopes recognized by mAbs NC16a-1 and NC16a-3
were determined using a peptide scan according to the manufac-
turer’s instructions (JPT Peptide Technologies, Berlin, Germany)
using horseradish peroxidase-coupled anti-mouse IgG and Roche
Lumi-Light Western Blotting Substrate (Roche, Mannheim, Ger-
many). Optimal binding for NC16a-1 was at 1:50,000 dilution. After
stripping with low pH, the membrane was reprobed with NC16a-3
diluted 1:10.
Cell cultures
Normal human keratinocytes were cultured in serum-free keratino-
cyte growth medium (Life Technologies Inc., Grand Island, NY) as
described (Schacke et al., 1998). The human keratinocyte cell line
HaCaT was a generous gift of Dr N. Fusenig (German Cancer
Research Center, Heidelberg, Germany). Before the experiments,
cells were grown in the presence of 50 mgml1 L-ascorbate for
48 hours. When appropriate, HaCaT cells were subsequently
washed once with PBS before fresh serum-free medium with and
without 0.5Uml1 plasmin (Calbiochem, La Jolla, CA), 0.25Uml1
human leucocyte elastase, 1mM human trypsin, or human chymo-
trypsin (Sigma-Aldrich, Taufkirchen, Germany) were added.
Skin blisters
Suction blisters were induced on healthy forearm skin of volunteers
using a suction device (Atmos S351; Atmos Medizintechnik,
Lenzkirch, Germany) and were punctured directly or after 4, 6, 10,
or 20 hours. Blister fluids from BP patients or suction blisters were
dialyzed against PBS with 8 kDa MWCO (GE Healthcare, Munich,
Germany) for 4 hours at 4 1C and were stored at 80 1C until use.
Protein extractions
For protein extractions, cell layer and media were processed
separately as described (Schacke et al., 1998). In addition to 1mM
Pefabloc (Merck, Darmstadt, Germany), 4mM EDTA, 10ml ml1
protease inhibitor cocktail set III (Calbiochem, Darmstadt, Ger-
many), 14 mgml1 chymostatin and 10mM 1,10-ortho-phenanthro-
line were added to the extraction buffer. The cells were incubated in
lysis buffer on ice for 10minutes, scraped off and centrifuged at
14,000 g for 30minutes at 4 1C. Total protein content was
determined using a micro-Lowry assay kit (Bio-Rad, Munich,
Germany) and 40mg total protein were loaded per slot for
SDS–PAGE.
The medium was collected on ice, proteinase inhibitors were
added immediately and cell debris removed by centrifugation.
Proteins were precipitated with chloroform–methanol, centrifuged,
and pellets resulting from 1ml of cell culture supernatant were
dissolved in 10 ml SDS–PAGE buffer.
Immunoprecipitation and immunoblotting
For immunoprecipitation, cell media or 100ml dialyzed blister fluid
were precleared with protein A-Sepharose 4 Fast Flow (Amersham
Pharmacia Biotech) for 30minutes and centrifuged at 2,000 g for
5minutes. The supernatants were incubated with 100 ml of mAb
NC16a-1 overnight at 4 1C and subsequently added to 200ml protein
A-Sepharose for 4 hours at 4 1C. After extensive washing, collagen
XVII was eluted with blue sample buffer containing 0.01M
dithiothreitol and heating at 95 1C for 5minutes.
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For immunoblotting, cell extracts, media, recombinant NC16a
proteins and purified or immunoprecipitated collagen XVII were
subjected to 8% SDS–PAGE under reducing conditions and transferred
to nitrocellulose. The mAb against human plasminogen/plasmin was
purchased from R&D (Wiesbaden, Germany). Different domain-
specific collagen XVII antibodies were used: mouse-mAb against the
intracellular domain V5–8, at a dilution of 1:500 (Immundiagnostik,
Bensheim, Germany), polyclonal chicken-antibody Ecto-1 against AA
1,292–1,497 diluted to 1:50 (Schacke et al., 1998), mouse-mAb
NC16a-1 diluted to 1:2 and mouse-mAb NC16a-3 diluted to 1:5,000,
polyclonal rabbit-anti NC16a-Ab at a dilution of 1:2,000 (Schumann
et al., 2000), or serum of patients with LAD diluted to 1:50.
Incubations with primary antibodies were overnight at 4 1C and with
alkaline phosphatase labeled anti-human IgG (1:30,000; Sigma-
Aldrich, St Louis, MO), horseradish peroxidase-labeled (HRP)-anti-
mouse IgG (1:3,000; Bio-Rad), HRP-anti-rabbit IgG (1:5,000; KPL,
Gaithersburg, MD) or HRP-anti-chicken IgGY (1:20,000; Sigma-
Aldrich), respectively, for 2hours at room temperature.
Heparin-affinity chromatography
The culture media of normal and plasmin-treated keratinocytes were
precipitated with 45% ammonium sulfate and dialysed against
20mM Tris-HCl, pH 7.4 at 4 1C overnight. After clearing by
centrifugation with 13,000 g for 10minutes, the supernatant was
analyzed by HPLC with a HiTrap Heparin HP column. The bound
ectodomain was eluted with a gradient from 0 to 1M NaCl in 20mM
Tris-HCl, pH 7.2 at a flow rate of 250ml minute1. All fractions were
screened for collagen XVII immunoreactivity by immunoblotting
with rabbit-anti-NC16a antibody and the density of the blots was
calculated using the software TotalLab1D V1.00 from Phoetix
(Biostep GmbH, Jahnsdorf, Germany).
Enzyme digestions of purified collagen XVII
Heparin-affinity-purified collagen XVII was digested with 1 mM
human trypsin, 0.25Uml1 human leucocyte elastase, 1mM human
chymotrypsin (Sigma-Aldrich), and 0.5Uml1 human plasmin
(Calbiochem) for 2 hours at 37 1C. The reactions were stopped with
1mM Pefabloc and immediately precipitated with methanol/chloro-
form for immunoblotting with collagen XVII directed antibodies. For
removal of N-linked carbohydrate residues, samples of concentrated
cell medium containing 50 mg protein were treated with 10%
b-mercaptoethanol for 10minutes at 100 1C before digestion with
10Uml1 N-glycosidase F (PNGase F) overnight at 37 1C (New
England Biolabs, Frankfurt, Germany).
Chromogenic assay for serine protease activity
Blister fluid (20 ml) of BP patients or of directly punctured suction
blisters was mixed with either 0.6mM N-succinyl-L-alanyl-L-alanyl-L-
alanine 4-nitroanilide or 0.6mM N-(p-Tosyl)-Gly-Pro-Lys 4-nitroani-
lide acetate (Sigma-Aldrich) in 200 ml 50mM Tris-HCL, 150mM
NaCl, pH 8.0. Blister fluids were analyzed in duplicates and
changing of absorbance was followed spectrophotometrically at
405 nm for 200minutes (OD405nm). The assay was calibrated using
1.5 ml of human plasmin per well (Calbiochem).
Ethics committee and animal experiment approval
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